The company
Medtronic plc.
MDT · NYSE
Health CareMedical DevicesAbove a falling averageRobotics
MDT stood above a rising 150-day average in 19 of the last 52 weekly readings, and has been out of that trend for the last 33 weeks. It is 11.3% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 33
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $20.5M
- Officials’ trades on record
- 228
- Institutions holding
- 2,014 (-103)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.
17 Apr – 16 Oct
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
1 Nov 2024 – 1 Oct 2026
Open-market buys above the line and sales below, in dollars.
Congress and officials
228 disclosed lines: House 178, Senate 28, executive 22; 69 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Kevin Hern House: U.S. House ClerkOK01 | soldjoint | $15k–$50k | 24 Aug 2026filed 1 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $500k–$1M | 21 Aug 2026filed 8 Oct 2026 |
| Richard McCormick House: U.S. House ClerkGA06 | sold | $1k–$15k | 30 Jul 2026filed 14 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 17 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 8 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 22 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 16 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $100k–$250k | 12 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $100k–$250k | 20 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 15 May 2026filed 1 Jul 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | sold | $1k–$15k | 15 May 2026filed 8 Jun 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $100k–$250k | 11 May 2026filed 1 Jul 2026 |
Insiders
Buy orders, 12 months0
Sale orders, 12 months7
Buyers · sellers0 · 5
| Who | Did | Shares | Traded |
|---|---|---|---|
| Geoffrey MarthaChairman and CEO | sold | 50,000at $95.00 | 15 Oct 2026filed 16 Oct 2026 |
| Michael MarinaroEVP, Pres MedSurg and Americas | sold | 10,420at $96.00 | 15 Oct 2026filed 16 Oct 2026 |
| Harry Skip KiilEVP & President Cardiovascular | sold | 1,483at $93.65 | 16 Sep 2026filed 17 Sep 2026 |
| Matthew R. WalterSVP, Chief HR Officer | sold | 3,102at $83.15 | 8 Jul 2026filed 9 Jul 2026 |
| Harry Skip KiilEVP & President Cardiovascular | sold | 3,961at $80.44 | 8 Jun 2026filed 9 Jun 2026 |
| Harry Skip KiilEVP & President Cardiovascular | sold | 228at $80.45 | 8 Jun 2026filed 9 Jun 2026 |
| Harry Skip KiilEVP & President Cardiovascular | sold | 1,648at $97.86 | 19 Feb 2026filed 26 Feb 2026 |
| Harry Skip KiilEVP & President Cardiovascular | sold | 30,568at $97.66 | 19 Feb 2026filed 26 Feb 2026 |
| Harry Skip KiilEVP & President Cardiovascular | sold | 19,255at $97.77 | 19 Feb 2026filed 26 Feb 2026 |
| Harry Skip KiilEVP & President Cardiovascular | sold | 668at $97.83 | 19 Feb 2026filed 26 Feb 2026 |
| Harry Skip KiilEVP & President Cardiovascular | sold | 385at $97.82 | 19 Feb 2026filed 26 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Holders2,014-103 on the quarter
New · exited167 · 272
Reported value$84.0B
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 114,020,787$8.9B | +838,220+0.7% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 83,816,735$6.6B | +482,902+0.6% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 63,399,315$5.0B | +1,658,301+2.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 34,059,967$2.7B | +609,409+1.8% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 30,192,015$2.4B | +1,455,674+5.1% |
| JPMORGAN CHASE & COnew · filed 12 Aug 2026 | 27,784,471$2.2B | +27,784,471 |
| BANK OF AMERICA CORPreduced · filed 14 Aug 2026 | 21,322,401$1.7B | -4,692,602−18.0% |
| MASSACHUSETTS FINANCIAL SERVICES COreduced · filed 3 Aug 2026 | 19,872,600$2.6B | -1,564,999−7.3% |
| MORGAN STANLEYreduced · filed 13 Aug 2026 | 19,444,871$1.5B | -1,272,158−6.1% |
| DEUTSCHE BANK AG\reduced · filed 7 Aug 2026 | 18,449,877$1.4B | -552,537−2.9% |
31 Mar 2023 – 30 Jun 2026
News
Medtronic: How an Olympic Runner Found Relief From Fecal Incontinencefinanznachrichten.de · 19 Oct 2026Medtronic Completes MiniMed Separation After Oversubscribed Exchangefinchannel.com · 18 Oct 2026Medtronic Pays More Today. Abbott Raises Its Dividend Faster. Which Stock Wins?247wallst.com · 14 Oct 2026Medtronic's Modest Valuation Meets an Improving Growth Outlookinsidermonkey.com · 11 Oct 2026Jim Cramer Has Very Different Views on MiniMed (MMED) and Medtronic (MDT)insidermonkey.com · 11 Oct 2026Medtronic - MDT - Stock Price & News | The Motley Foolfool.com · 8 Oct 2026Is Medtronic (MDT) On Its Way to Become a Multi-Platform Powerhouse?insidermonkey.com · 8 Oct 2026Medtronic Is Just 1 Year From Dividend King Status. Should You Buy the Stock Before It Gets There?aol.com · 8 Oct 2026
Everyone who traded it
Same industry
Government contracts
Awards51
Total$4.1M
Latest11 Nov 2026
From its SEC filings
Analyst forecasts
No analyst forecasts yet.